Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The Latest Research and Clinical Trials for ER+ and Triple-Negative Metastatic Breast Cancer


Published on

Nancy Lin, MD, medical oncologist at the Susan F. Smith Center for Women's Cancers at Dana-Farber, discusses the latest treatment and research for ER+ and triple-negative breast cancers. This presentation was originally given at the Metastatic Breast Cancer Forum, held on Oct. 18, 2014 at Dana-Farber Cancer Institute.

Published in: Health & Medicine
  • Be the first to comment